ConductScience.org, home

Paper17794

Drug utilization review in an HMO. I. Introduction and examples of methodology.

West SK and 6 others. Med Care, 1977. Cited by 19 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Drug utilization review in an HMO. I. Introduction and examples of methodology. Papers, record 17794. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17794

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Drug utilization review in an HMO. I. Introduction and examples of methodology.
PubMed
Journal
Med Care
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
1.5
iCite
Revised in PubMed
2019-08-19
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1West SKS K
2Brandon BMB M
3Stevens AMA M
4Zauber AA
5Chase GG
6Stolley PDP D
7Rumrill RER E

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug UtilizationMajor topic
Health Maintenance OrganizationsMajor topic
Adolescent
Adult
Aged
Child
Child, Preschool
Drug Combinations
Histamine H1 Antagonists
Humans
Internal Medicine
Maryland
Methods
Middle Aged
Pediatrics
Respiratory Tract Diseases
Seasons
Virus Diseases

Source PubMed

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
10,146,976Pharmacoeconomic consequences of measurement and modification of hospital drug use.Pharmacoeconomics1992https://conductscience.org/library/papers/10146976PubMed
10,146,909The cost effectiveness of drug utilisation review in an outpatient setting.Pharmacoeconomics1993https://conductscience.org/library/papers/10146909PubMed
9,383,135A computerized intervention to decrease the use of calcium channel blockers in hypertension.J Gen Intern Med1997https://conductscience.org/library/papers/9383135PubMed
7,316,001Do prescriptions adversely affect doctor-patient interactions?Am J Public Health1981https://conductscience.org/library/papers/7316001PubMed
6,133,539Are benzodiazepines overused and abused?Br J Clin Pharmacol1981https://conductscience.org/library/papers/6133539PubMed
2,076,739Paediatric prescribing in out-patient care. An example from Sri Lanka.Eur J Clin Pharmacol1990https://conductscience.org/library/papers/2076739PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17794

GET https://conductscience.org/api/papers/v1/17794/authors